FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2107096899> ?p ?o ?g. }

• W2107096899 endingPage "1311" @default.
• W2107096899 startingPage "1303" @default.
• W2107096899 abstract "To evaluate the preclinical erythropoiesis stimulating properties of Hematide, a novel, PEGylated, synthetic peptide for the treatment of anemia associated with chronic kidney disease and cancer.The in vitro activity of Hematide was assessed in competitive binding, proliferation, signal transduction, and apoptosis assays, and in erythroid colony-forming assays with CD34(+) cells purified from human bone marrow. Erythropoiesis and pharmacokinetics were evaluated in rat, monkey, and a rat chronic renal insufficiency (CRI) model following single administration. Erythropoiesis and immunogenicity were also evaluated following repeat administration in rats.Hematide binds and activates the erythropoietin receptor and causes proliferation and differentiation of erythroid progenitor cells. Sustained circulatory persistence of Hematide is observed in rats and monkeys. In a rat CRI model, Hematide exhibited twofold lower clearance than in the normal rat, with hypothesis consistent with Hematide being cleared, at least partially, via the kidney. A dose-dependent rise in hemoglobin (Hgb) and duration of response was observed following single administration in rats and monkeys. Hematide was able to alleviate anemia in an experimental CRI rodent model. Repeat intravenous (IV) and subcutaneous (SC) administration in rats yielded similar erythrogenic responses, with no anti-Hematide antibodies being detected.Hematide is a potent erythropoiesis stimulating agent with a prolonged half-life and slow clearance times. It is anticipated that similar prolonged clearance and activity will be observed in the clinic, potentially enabling dosing intervals of 3 to 4 weeks that may translate into improved patient convenience for the treatment of anemia." @default.
• W2107096899 created "2016-06-24" @default.
• W2107096899 creator A5000095180 @default.
• W2107096899 creator A5011522761 @default.
• W2107096899 creator A5013471328 @default.
• W2107096899 creator A5024180072 @default.
• W2107096899 creator A5028199089 @default.
• W2107096899 creator A5030711643 @default.
• W2107096899 creator A5038489540 @default.
• W2107096899 creator A5044374579 @default.
• W2107096899 creator A5048901432 @default.
• W2107096899 creator A5050796287 @default.
• W2107096899 creator A5080637068 @default.
• W2107096899 creator A5083682097 @default.
• W2107096899 date "2006-10-01" @default.
• W2107096899 modified "2023-10-09" @default.
• W2107096899 title "Preclinical evaluation of Hematide, a novel erythropoiesis stimulating agent, for the treatment of anemia" @default.
• W2107096899 cites W1577603732 @default.
• W2107096899 cites W1987888718 @default.
• W2107096899 cites W1999997293 @default.
• W2107096899 cites W2016519305 @default.
• W2107096899 cites W2051066066 @default.
• W2107096899 cites W2051611532 @default.
• W2107096899 cites W2069995085 @default.
• W2107096899 cites W2086437884 @default.
• W2107096899 cites W2088363096 @default.
• W2107096899 cites W2110903565 @default.
• W2107096899 cites W2114918609 @default.
• W2107096899 cites W2123200029 @default.
• W2107096899 cites W2127926928 @default.
• W2107096899 cites W2169177790 @default.
• W2107096899 cites W2260662236 @default.
• W2107096899 cites W2338061499 @default.
• W2107096899 cites W4232969398 @default.
• W2107096899 doi "https://doi.org/10.1016/j.exphem.2006.05.012" @default.
• W2107096899 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16982323" @default.
• W2107096899 hasPublicationYear "2006" @default.
• W2107096899 type Work @default.
• W2107096899 sameAs 2107096899 @default.
• W2107096899 citedByCount "108" @default.
• W2107096899 countsByYear W21070968992012 @default.
• W2107096899 countsByYear W21070968992013 @default.
• W2107096899 countsByYear W21070968992014 @default.
• W2107096899 countsByYear W21070968992015 @default.
• W2107096899 countsByYear W21070968992016 @default.
• W2107096899 countsByYear W21070968992017 @default.
• W2107096899 countsByYear W21070968992018 @default.
• W2107096899 countsByYear W21070968992021 @default.
• W2107096899 countsByYear W21070968992022 @default.
• W2107096899 crossrefType "journal-article" @default.
• W2107096899 hasAuthorship W2107096899A5000095180 @default.
• W2107096899 hasAuthorship W2107096899A5011522761 @default.
• W2107096899 hasAuthorship W2107096899A5013471328 @default.
• W2107096899 hasAuthorship W2107096899A5024180072 @default.
• W2107096899 hasAuthorship W2107096899A5028199089 @default.
• W2107096899 hasAuthorship W2107096899A5030711643 @default.
• W2107096899 hasAuthorship W2107096899A5038489540 @default.
• W2107096899 hasAuthorship W2107096899A5044374579 @default.
• W2107096899 hasAuthorship W2107096899A5048901432 @default.
• W2107096899 hasAuthorship W2107096899A5050796287 @default.
• W2107096899 hasAuthorship W2107096899A5080637068 @default.
• W2107096899 hasAuthorship W2107096899A5083682097 @default.
• W2107096899 hasBestOaLocation W21070968991 @default.
• W2107096899 hasConcept C112705442 @default.
• W2107096899 hasConcept C126322002 @default.
• W2107096899 hasConcept C134018914 @default.
• W2107096899 hasConcept C159654299 @default.
• W2107096899 hasConcept C201750760 @default.
• W2107096899 hasConcept C203014093 @default.
• W2107096899 hasConcept C2778248108 @default.
• W2107096899 hasConcept C2778534260 @default.
• W2107096899 hasConcept C2779703530 @default.
• W2107096899 hasConcept C2780007613 @default.
• W2107096899 hasConcept C2780868878 @default.
• W2107096899 hasConcept C28328180 @default.
• W2107096899 hasConcept C71924100 @default.
• W2107096899 hasConcept C86803240 @default.
• W2107096899 hasConcept C95444343 @default.
• W2107096899 hasConcept C98274493 @default.
• W2107096899 hasConceptScore W2107096899C112705442 @default.
• W2107096899 hasConceptScore W2107096899C126322002 @default.
• W2107096899 hasConceptScore W2107096899C134018914 @default.
• W2107096899 hasConceptScore W2107096899C159654299 @default.
• W2107096899 hasConceptScore W2107096899C201750760 @default.
• W2107096899 hasConceptScore W2107096899C203014093 @default.
• W2107096899 hasConceptScore W2107096899C2778248108 @default.
• W2107096899 hasConceptScore W2107096899C2778534260 @default.
• W2107096899 hasConceptScore W2107096899C2779703530 @default.
• W2107096899 hasConceptScore W2107096899C2780007613 @default.
• W2107096899 hasConceptScore W2107096899C2780868878 @default.
• W2107096899 hasConceptScore W2107096899C28328180 @default.
• W2107096899 hasConceptScore W2107096899C71924100 @default.
• W2107096899 hasConceptScore W2107096899C86803240 @default.
• W2107096899 hasConceptScore W2107096899C95444343 @default.
• W2107096899 hasConceptScore W2107096899C98274493 @default.
• W2107096899 hasIssue "10" @default.
• W2107096899 hasLocation W21070968991 @default.
• W2107096899 hasLocation W21070968992 @default.

• next